Epoprostenol and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Epoprostenol (epoprostenol), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Opsumit, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Epoprostenol. It is created by eHealthMe based on reports of 883 people who have side effects when taking Epoprostenol from the FDA, and is updated regularly.

What is Epoprostenol?

Epoprostenol has active ingredients of epoprostenol. eHealthMe is studying from 883 Epoprostenol users. Check the latest studies of Epoprostenol.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,553 drugs and 4,589 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On Jul, 17, 2026

883 people reported to have side effects when taking Epoprostenol.
Among them, 26 people (2.94%) have Appetite - decreased.

Could Epoprostenol cause Appetite - decreased?

Among these 26 people:

How long have people been on Epoprostenol when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Epoprostenol? *

female: 75 %
male: 25 %

What is the age of people who have Appetite - decreased when taking Epoprostenol? *

What are other drugs people take besides Epoprostenol? *

What are other side effects people have besides Appetite - decreased? *

Nausea (feeling of having an urge to vomit): 15 people, 57.69%
Diarrhea: 14 people, 53.85%
Weight Decreased: 14 people, 53.85%
Nausea And Vomiting: 10 people, 38.46%
Weakness: 8 people, 30.77%
Dyspnea (difficult or laboured breathing): 7 people, 26.92%
Pain: 7 people, 26.92%
Hypotension (abnormally low blood pressure): 7 people, 26.92%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 26.92%
Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 26.92%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 21 people, 80.77%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 19.23%
Coughing Up Blood: 2 people, 7.69%
Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 1 person, 3.85%
Sedation: 1 person, 3.85%
Right Ventricular Failure (right half of the heart fails to work): 1 person, 3.85%
Rashes (redness): 1 person, 3.85%
Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 1 person, 3.85%
Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 1 person, 3.85%
Joint Pain: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Epoprostenol and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Epoprostenol:

Epoprostenol (883 reports)

Browse all side effects of Epoprostenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,553 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,589 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epoprostenol (the active ingredients of Epoprostenol) and Epoprostenol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.